Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

Building Global Antibiotic Resistance Monitoring Capacities

JUL 21, 2020 | GRANT M. GALLAGHER
Segment Description: Dr. Pol Vandenbroucke, Chief Medical Officer for Pfizer’s hospital business unit, describes efforts to build up capacity for antimicrobial resistance surveillance in low- and middle-income countries. Dr. Vandenbroucke also explains how the development of both health and civil society infrastructure around the world helps to slow antimicrobial resistance.

To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.